FDA Inspection 955256 — Heartland Center for Reproductive Medicine, PC
The FDA completed an inspection of Heartland Center for Reproductive Medicine, PC on January 14, 2016 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 14, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Omaha, NE (United States)